Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The rise of pathogens increasingly resistant to all known antibiotics is becoming an alarming and pressing health care problem. Despite considerable efforts towards finding new antibiotics with novel targets; bacteria will eventually develop resistance against these new classes of drugs. Designing alternative therapeutics with much improved efficacy?without conferring further resistance?is therefore warranted. My research proposal aims to contribute to this global effort by employing polyserotonin nanoparticles (PSeNPs) as an anti-bacterial agent. Through my Mitacs Globalink host, I will decorate the surface of my PSeNPs with polymers exhibiting antifouling properties, tuned for different grafting densities. The resulting polymer-modified PSeNP (PM-PSNP), along with PSeNPs’ intrinsic bacterial-killing property, will then be tested for its anti-adhesion/anti-microbial activities against S. mutans, an oral pathogen responsible for dental caries. TO BE CONT’D
Ruby Sullan
Queensland University of Technology
Life Sciences
Education
University of Toronto
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.